Table 2.
Discontinuation rates by intervention and study type.
| MMF | MTX | AZA | IVC | Oral CYC | CsA | |
|---|---|---|---|---|---|---|
| RCTs (n = 11) | 1.4–13% | 12.2% | 2.3–20% | 2.9–7.7% | 9.7–44.4% | 13.9–17.0% |
| Observational (n = 11) | 0–16.7% | 8.3–11% | 19–21.8% | 1.9–18.8% | 5.6% | 16.1% |
AZA: azathioprine; CsA: cyclosporine; CYC: cyclophosphamide; IVC: intravenous cyclophosphamide; MMF: mycophenolate mofetil; MTX: methotrexate; N/A: not available; RCT: randomized controlled trial.